Intellipharmaceutics International Inc. Annual Revenues in CAD from 2014 to 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Intellipharmaceutics International Inc. annual/quarterly Revenues history and growth rate from 2014 to 2018.
  • Intellipharmaceutics International Inc. Revenues for the quarter ending May 31, 2017 was CA$2M, a 260% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Revenues for 2018 was CA$1.71M, a 68.9% decline from 2017.
  • Intellipharmaceutics International Inc. annual Revenues for 2017 was CA$5.5M, a 145% increase from 2016.
  • Intellipharmaceutics International Inc. annual Revenues for 2016 was CA$2.25M, a 45.1% decline from 2015.
Revenues, Annual (CAD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 1.71M -3.79M -68.9% Dec 1, 2017 Nov 30, 2018 20-F/A 2019-03-04
2017 5.5M +3.26M +145% Dec 1, 2016 Nov 30, 2017 20-F/A 2019-03-04
2016 2.25M -1.85M -45.1% Dec 1, 2015 Nov 30, 2016 20-F/A 2019-03-04
2015 4.09M -4.68M -53.3% Dec 1, 2014 Nov 30, 2015 20-F 2018-03-01
2014 8.77M Dec 1, 2013 Nov 30, 2014 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.